Helping to Create New Possibilities for People with Primary Biliary Cholangitis (PBC)

Pill bottles in a manufacturing facility

The FDA has granted accelerated approval for a new therapy for PBC, a liver disease that can lead to chronic itch. This development builds on our legacy of innovation in liver disease.

Our Purpose

Scientific Innovation

We discover, develop and deliver medicines for the world’s most devastating diseases, from viruses to cancer to inflammatory conditions.

A young woman and an older woman embracing

Access & Health Equity

We’re partnering with communities around the world to remove societal barriers to care, improve health equity and make our medicines available to those who need them most.

A smiling Gilead employee in a manufacturing facility

Our People & Culture

We foster an environment of inclusion and growth where our 18,000+ employees around the world are empowered to make a real impact.

We’ve been taking on the world’s biggest health challenges for more than 35 years. We continue to set and achieve ambitious goals to create a healthier world for all people.

Our Mission